Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |